✦ LIBER ✦

A Double-Blind Placebo Controlled Trial ofGinkgo bilobaAdded to Risperidone in Patients with Autistic Disorders

✍ Scribed by Elmira Hasanzadeh, Mohammad-Reza Mohammadi, Ahmad Ghanizadeh, Shams-Ali Rezazadeh, Mina Tabrizi, Farzin Rezaei, Shahin Akhondzadeh

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind, placebo-controlled trial o

✍ Vala Rezaei; Mohammad-Reza Mohammadi; Ahmad Ghanizadeh; Ali Sahraian; Mina Tabri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Secretin in Children with Autistic Disor

✍ Benjamin L. Handen; Dena Hofkosh 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 146 KB

Cyproheptadine in the treatment of autis

✍ S. Akhondzadeh; S. Erfani; M. R. Mohammadi; M. Tehrani-Doost; H. Amini; S. S. Gu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

A Double-Blind, Placebo-Controlled, Cros

✍ William M. Bolman; John A. Richmond 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 379 KB

A randomized, double-blind, placebo-cont

✍ Eduard Vieta; Stuart Montgomery; Ahmad Hatim Sulaiman; Rodrigo Cordoba; Benedict 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 330 KB

P2.104 Efficacy and safety of risperidon

✍ M. Light; F. Dunbar; S.E. Shea 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 116 KB